This randomized experiment measured a mitochondrial response in a hand muscle. Its physiological and functional findings should not be merged into a claim of improved stamina. Primary study
What was studied
Thirty-nine older adults selected for low mitochondrial function received elamipretide or placebo. Immediate ATP-capacity results differed by analysis: absolute change had P=0.055 and percentage change P=0.045. The difference was absent at day seven. Resting mitochondrial coupling and the reported fatigue-resistance endpoint were not significantly improved. Primary report
Our appraisal: the analysis scale belongs beside the result
A result just above a conventional threshold and another just below it should not be described as two entirely different biological realities. The more useful questions concern effect size, uncertainty and which analysis was prespecified. Choosing the favorable scale after seeing the results would give a misleading impression of certainty.
The selected population also matters. Participants with low measured function are not necessarily representative of every older adult. Eligibility may make a biological response easier to observe while narrowing generalizability. The hand-muscle measurement cannot automatically describe whole-body exercise capacity or everyday mobility.
Functional testing is a separate part of the evidence. A marker response can justify further research even when a functional endpoint is neutral, but it cannot replace that endpoint. Conversely, a small study may be unable to rule out modest functional effects; “not established” is more accurate than either “proven beneficial” or “proven useless.”
The short-lived observation does not establish an effective repeat-treatment schedule. That would require a different design with longer exposure, clinically meaningful outcomes and appropriate harms monitoring. The appropriate takeaway is a tentative acute bioenergetic signal with important neutral findings, not evidence of rejuvenation or guaranteed fatigue relief.
Frequently asked questions
Was the study randomized?
Yes.
Did both ATP analyses meet P<0.05?
No.
Was the ATP difference still present at day seven?
Not in the reported comparison.
Did fatigue resistance significantly improve?
No.
Did resting coupling significantly improve?
No.
Were all older adults represented?
No; eligibility selected low mitochondrial function.
Does this establish a repeat-use regimen?
No.